Effects of Agility Training With and Without Foot Mobilization In Patellofemoral Pain Syndrome.
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Nov 3, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how agility training, both with and without foot mobilization, can help people with patellofemoral pain syndrome (PFPS). PFPS is a common knee condition that causes pain around the kneecap, often due to changes in how the knee functions. The goal of the study is to find out if these training methods can reduce pain, improve balance, and enhance overall physical performance in individuals affected by this condition.
To participate in the trial, you need to be between 20 and 40 years old and have been experiencing symptoms of PFPS, like knee pain during certain activities, for more than six months. Participants should also show specific signs of pain and imbalance. If you have a history of serious knee injuries, surgeries, or other medical conditions affecting your legs, you may not be eligible. If you join, you can expect to engage in agility training sessions and possibly receive foot mobilization treatment to see how these methods can benefit your knee health. This study is currently recruiting participants, and everyone is welcome to apply, regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical signs of patellofemoral pain syndrome such as retro patellar pain, crepitation, and pain with patellar grinding more than 6 months.
- • Both genders of 20-40 years of age.
- • Presence of pain on step down from a 25 step or double leg squat and sitting with knee bent greater than 15 min.
- • Pain more than 4 on NPRS scale.
- • Individual with anterior left/right asymmetries greater than 4 cm on Y balance test
- • Excessive calcaneal eversion measured at 6° in the relaxed posture(6).
- Exclusion Criteria:
- • History of ligament and meniscal injury.
- • History of lower limb fractures.
- • History of post-surgical condition of lower limb
- • History of systemic, connective tissue or neurologic condition
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Ali Raza, MS-OMPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported